In this meta-analysis, we discussed recent advances in the research of KRAS in cancer, with an emphasis on the KRAS expression levels and their biological functions in various cancer types, which provides better knowledge for the exploration of prognosis biomarkers and immunotherapeutic targets in clinical strategies (Figure 12). The gene discussed is KRAS; the disease is cancer.